Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3252245 | 0.89 | GRIK1 (0.51) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL5010036 | 0.86 | TSHR (0.43) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL7319532 | 0.86 | MAPT (0.51) | KMT2AHPGDALDH1A1 | |
| SCHEMBL3392225 | 0.85 | TSHR (0.51) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL27453354 | 0.85 | SLC1A3 (0.51) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL30136419 | 0.83 | TDP1 (0.45) | TSHRSMN1; SMN2KMT2AHPGDALDH1A1 | |
| SCHEMBL7698714 | 0.82 | TSHR (0.45) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL7698716 | 0.82 | TSHR (0.45) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL20363269 | 0.82 | TSHR (0.49) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL7698712 | 0.82 | TSHR (0.45) | TSHRSMN1; SMN2KMT2AMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444108-B1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| EP-4161293-B1 | FLAVOURING COMPOSITION WITH BALANCED TASTE PROFILE | SYMRISE AG (DE) | 2024-01-31 | — | — | EP | claimed |
| CN-117396591-A | Fragrance and evaluation method for improving happy state | 奇华顿股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| EP-4161291-B1 | FLAVORING COMPOSITIONS FOR TASTE IMPROVEMENT | SYMRISE AG (DE) | 2023-11-01 | — | — | EP | claimed |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SYMRISE AG (DE) | 2020-12-29 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| EP-3006547-B1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO CO LTD (JP) | 2019-10-30 | — | — | EP | claimed |
| EP-2742983-B1 | Method for isolating fragrance and flavour compounds | SYMRISE AG (DE) | 2017-08-23 | — | — | EP | claimed |
| EP-2849718-B1 | MIXTURES HAVING IMPROVED COOLING EFFECT | SYMRISE AG (DE) | 2017-02-01 | — | — | EP | claimed |
| US-9005688-B2 | Thermally stable high impact flavoring particles | SYMRISE AG (DE) | 2015-04-14 | — | — | US | claimed |
| EP-2849718-A2 | MIXTURES HAVING IMPROVED COOLING EFFECT | Symrise AG (DE) | 2015-03-25 | — | — | EP | claimed |
| WO-2013171018-A2 | MIXTURES HAVING IMPROVED COOLING EFFECT | SYMRISE AG (DE) | 2013-11-21 | — | — | WO | claimed |
| US-20120107477-A1 | THERMALLY STABLE HIGH IMPACT FLAVORING PARTICLES | SYMRISE AG (DE) | 2012-05-03 | — | — | US | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-3663366-B1 | USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS | SYMRISE AG (DE) | 2025-01-08 | — | — | EP | disclosed |
| CN-113950465-B | Sandalwood type spice compound | 西姆莱斯股份公司 | 2024-09-20 | — | — | CN | disclosed |
| WO-2002041861-A1 | RHINOLOGICAL AGENTS | HAARMANN & REIMER GMBH (DE) | 2002-05-30 | — | — | WO | disclosed |
| WO-2001043567-A1 | AROMAS AND AROMA COMPOSITIONS CONTAINING 4,8-DIMETHYL-3,7-NONADIEN-2-ONE, AND A METHOD FOR THE PRODUCTION THEREOF | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
| EP-1050574-A2 | Mint and/or fruit flavour compositions | HAARMANN & REIMER GMBH (DE) | 2000-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SMOX, LIPA, SGMS2 | TSHR 4699/4885SMN1; SMN2 1541/4885KMT2A 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.